ENVUE MEDICAL INC NEW
FEED
FEED was delisted on the 15th of September, 2026.
8 hedge funds and large institutions have $242K invested in ENVUE MEDICAL INC NEW in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
100% more funds holding
Funds holding: 4 → 8 (+4)
70% more capital invested
Capital invested by funds: $142K → $242K (+$100K)
4.94% more ownership
Funds ownership: 2.49% → 7.43% (+4.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$78.6K |
| 2 |
HF
HRT Financial
New York
|
+$35.7K |
| 3 |
VF
Virtu Financial
New York
|
+$35.7K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$25K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
NewSquare Capital
Newtown Square,
Pennsylvania
|
-$34 |
FEED Hedge Fund Activity: Q3 2023 in Review
8 of the 6,311 institutional investors tracked by Wall St. Rank reported a position in ENVUE MEDICAL INC NEW (FEED) for Q3 2023, worth a combined $242K — up 70% from $142K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new FEED positions and 0 closed out — a net gain of 4 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $78.6K. The largest seller was NewSquare Capital, cutting an estimated $34.
- 8 institutional investors held ENVUE MEDICAL INC NEW (FEED) as of Q3 2023, up from 4 in Q2 2023.
- Funds reported $242K of ENVUE MEDICAL INC NEW stock for Q3 2023, up 70% quarter-over-quarter.
- 4 funds opened new ENVUE MEDICAL INC NEW positions in Q3 2023 and 0 closed out, a net change of +4 holders.
- The largest ENVUE MEDICAL INC NEW buyer in Q3 2023 was Armistice Capital, an estimated $78.6K added.
- The largest ENVUE MEDICAL INC NEW seller in Q3 2023 was NewSquare Capital, an estimated $34 sold.
Based on aggregated 13F filings for Q3 2023.